GK1-399
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GK1-399, covering 2013-09-13 to 2013-09-13. Get the full timeline:
Most recent: Clinical Trial Update: A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes [Phase 1, Phase 2]